3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- manufacturers
- GSK251
-
- $166.00 / 1mg
-
2026-04-17
- CAS:2125968-05-8
- Min. Order:
- Purity: 99.80%
- Supply Ability: 10g
|
| | 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- Basic information |
| | 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- Chemical Properties |
| Boiling point | 742.4±70.0 °C(Predicted) | | density | 1.295±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 62.5 mg/mL (106.89 mM; ultrasonic and warming and heat to 60°C) | | form | Solid | | pka | -0.07±0.10(Predicted) | | color | Off-white to light yellow |
| | 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- Usage And Synthesis |
| Uses | GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode. | | References | [1] Down K, et al. Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode. J Med Chem. 2021 Sep 23;64(18):13780-13792. DOI:10.1021/acs.jmedchem.1c01102 |
| | 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- Preparation Products And Raw materials |
|